language Türkçe
SL

Saglam, Leyla

24 papers · 121 citations · 2021–2026

Publications
24
Citations
121
Years
6
Publications
Title Year Type Citations
Evaluation of ICAM and VCAM as biomarkers in serum and bronchoscopic lavage samples of lung cancer patients
CLINICAL & TRANSLATIONAL ONCOLOGY
2026 Article 0
Serum Ang 1, Ang 1-7, and Mas levels as potential biomarkers in obstructive sleep apnea syndrome
BIOMARKERS IN MEDICINE
2025 Article 0
Can apelins guide the diagnosis of coronary artery disease in COPD patients?
HEART & LUNG
2025 Article 1
The Importance of Multisystem Evaluation in Diagnosing Birt-Hogg-Dubé Syndrome: A Case Report
EURASIAN JOURNAL OF MEDICINE
2024 Letter 0
COMPARISON OF METHOTREXATE AND METHYLPREDNISOLONE AS ADDITION TO ANTIFIBROTIC THERAPY IN PROGRESSIVE PULMONARY FIBROSIS DUE TO COVID-19
SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES
2024 Article 1
The effect of compliance with PAP therapy on biochemical parameters in patients with obstructive sleep apnea syndrome: A 6-month follow-up study
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX
2024 Article 1
Evaluation of Pulmonary Function Tests, Dyspnea Scores, and Antibody Levels at the Six-Month Follow-Up of Patients Hospitalized for COVID-19 Pneumonia
CUREUS JOURNAL OF MEDICAL SCIENCE
2024 Article 1
Evaluation of Lipocalin-2 and-10 Levels at Time of Diagnosis in Patients with Acute Pulmonary Embolism
BIOCHEMISTRY MOSCOW-SUPPLEMENT SERIES B-BIOMEDICAL CHEMISTRY
2023 Article 0
Analysis of one-year follow-up results and treatment costs of patients with PTE in a tertiary care center
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX
2023 Article 0
Evaluation of the Relationship between FeNO and Clinical Risk Stratification for Early Mortality in Pulmonary Embolism
CLINICAL LABORATORY
2023 Article 0
Evaluation of the Effect of COVID-19 Lung Involvement on Cardiorespiratory Fitness at 3 and 6 months
JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION
2023 Letter 0
Effect of atmospheric pressure changes on the development of pulmonary embolism a retrospective analysis of 8 years of data
ANNALS OF SAUDI MEDICINE
2023 Article 2
Using clinical parameters to determine the optimal dose of thrombolytic treatment in acute pulmonary thromboembolism
EURASIAN JOURNAL OF PULMONOLOGY
2022 Article 0
Evaluation of serum YKL-40 level among clinical risk scores for early mortality in acute pulmonary thromboembolism
CLINICAL BIOCHEMISTRY
2022 Article 1
Investigation of the need for computed tomography pulmonary angiography in the decision to discontinue treatment for pulmonary thromboembolism
HEART & LUNG
2022 Article 0
Response to "An appraisal of high-flow nasal cannula oxygen therapy in hypoxic pulmonary embolism patients"
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX
2022 Letter 0
Evaluation of the relationship between KIM-1 and suPAR level in COVID-19 patients and a different perspective on suPAR
EUROPEAN RESPIRATORY JOURNAL
2021 Meeting Abstract 0
Comparison of the effectiveness of high-flow and conventional nasal cannula oxygen therapy in pulmonary embolism patients with acute hypoxemic respiratory failure
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX
2021 Article 4
Comparison of high-flow and conventional nasal cannula oxygen in patients undergoing endobronchial ultrasonography
INTERNAL MEDICINE JOURNAL
2021 Article 23
Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19
JOURNAL OF MEDICAL VIROLOGY
2021 Article 12
Could VEGF-D level have a role in clinical risk scoring, estimation of thrombus burden, and treatment in acute pulmonary thromboembolism?
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
2021 Article 6
Evaluation of the relationship between KIM-1 and suPAR levels and clinical severity in COVID-19 patients: A different perspective on suPAR
JOURNAL OF MEDICAL VIROLOGY
2021 Article 24
Can hematological parameters guide the differentiation between sarcoidosis and tuberculous lymphadenitis?
EURASIAN JOURNAL OF PULMONOLOGY
2021 Article 1
Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome
JOURNAL OF MEDICAL VIROLOGY
2021 Article 44